Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver Disease.
暂无分享,去创建一个
H. Isomoto | T. Sugihara | Kazuhiro Yamamoto | Yoshiki Hoshino | Suguru Ikeda | Yukako Matsuki | T. Nagahara | J. Okano | Youhei Fujioka | Sonoko Kitao